Treatment of type 2 diabetes with rosiglitazone associated with increased risk of cardiovascular events among older adults

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2008年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [41] Candidate genes associated with the effect of rosiglitazone on glycemic control and cardiovascular system in the treatment of type 2 diabetes mellitus
    Wu, Xiaoli
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 2039 - 2046
  • [42] Gender differences in cardiovascular risk profiles and diabetes care among adults with type 2 diabetes in Germany
    Du, Y.
    Baumert, J.
    Paprott, R.
    Neuhauser, H.
    Heidemann, C.
    Scheidt-Nave, C.
    DIABETES & METABOLISM, 2019, 45 (02) : 204 - 206
  • [43] Beneficial effects of combined treatment with rosiglitazone and exercise on 40 cardiovascular risk factors in patients with type 2 diabetes
    Kadoglou, Nikolaos P. E.
    Iliadis, Fotios
    Liapis, Christos D.
    Perrea, Despina
    Angelopoulou, Nikoleta
    Alevizos, Miltiadis
    DIABETES CARE, 2007, 30 (09) : 2242 - 2244
  • [44] Type 2 Diabetes Genetic Risk Scores Are Associated With Increased Type 2 Diabetes Risk Among African Americans by Cardiometabolic Status
    Layton, Jill
    Li, Xiaochen
    Shen, Changyu
    de Groot, Mary
    Lange, Leslie
    Correa, Adolfo
    Wessel, Jennifer
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2018, 11
  • [45] Barriers to Treatment Adherence Among Older Adults With Type 2 Diabetes: A Qualitative Study
    Maghsoudi, Zahra
    Sadeghi, Amir
    Oshvandi, Khodayar
    Ebadi, Abbas
    Tapak, Leili
    JOURNAL OF GERONTOLOGICAL NURSING, 2023, 49 (01): : 42 - 49
  • [46] Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes
    Manzali, Sigalit B.
    Yu, Eric
    Ravona-Springer, Ramit
    Livny, Abigail
    Golan, Sapir
    Ouyang, Yuxia
    Lesman-Segev, Orit
    Liu, Lang
    Ganmore, Ithamar
    Alkelai, Anna
    Gan-Or, Ziv
    Lin, Hung-Mo
    Heymann, Anthony
    Schnaider Beeri, Michal
    Greenbaum, Lior
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [47] INCREASED RISK OF SEVERE HYPOGLYCEMIC EVENTS BEFORE AND AFTER CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: VALIDATION OF A NOVEL CONCEPT
    Standl, Eberhard
    Stevens, Susanna
    Lokhnygina, Yuliya
    Buse, John
    Maggioni, Aldo
    Mentz, Robert
    Ramachandran, Ambady
    Hernandez, Adrian
    Holman, Rury
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 24 - 24
  • [48] Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
    Aryangat, Ajikumar V.
    Gerich, John E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 145 - 155
  • [49] Type 2 diabetes: increased cardiovascular risk in thyroid dysfunction?
    Andres, Ulrike
    DIABETOLOGIE UND STOFFWECHSEL, 2023, 18 (01) : 10 - 10
  • [50] The effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk
    Yee, M. S.
    Pavitt, D. V.
    Dhanjil, S.
    Godsland, I. F.
    Richmond, W.
    Johnston, D. G.
    DIABETIC MEDICINE, 2010, 27 (12) : 1392 - 1400
12345